Basic Sciences Symposium: Novel Technologies for Benign Urology Research

Welcome and Opening Remarks, Margot Damaser, PhD and Robert W. Gereau IV, PhD

Session One: Tissue Engineering and Nanotechnology, Moderator: Joshua Mauney, PhD

• Strategies to Optimize Stem Cell Therapy for Tissue Regeneration in Urology, Yuanyuan Zhang, MD, PhD
• Developing Tissue Engineered Solutions for Women with Stress Urinary Incontinence and Pelvic Organ Prolapse, Naside Mangir, MD, PhD, FEBU

Session Two: Technological Advances for Wireless Monitoring and Neural Control, Moderator: Robert W. Gereau IV, PhD

• Genetic and Circuit Framework of Amygdalar Neurons in Bladder Pain Processing, Vijay Samineni, PhD
• Inflammation and Bladder Brain Connectivity, Stephen Zderic, MD
• Advancing Closed-Loop Control of Bladder Function With Optogenetic Approaches, Aaron Mickle, PhD
• Real-time Wireless Pressure Sensing: Opportunities for Conditional Bladder Neuromodulation, Steve J.A. Majerus, PhD

Urologic Oncology Research Symposium: "Immune Checkpoint Inhibitors: Impact of Macro and Microenvironment on Efficacy"

Welcome and Opening Remarks, Peter Black, MD, FACS, FRCSC and William Kim, MD

Session One: Bladder Cancer, Moderator: David McConkey, PhD

• scRNAseq of urothelial cancer: comprehensive analysis of the tumor microenvironment, John P. Sfakianos, MD
• Role of the microenvironment in response to BCG treatment of bladder cancer, Robert Svatek, MD
• FGFR3 Alterations Regulate the Tumor Immune Environment and Impact Response to Immunotherapy, Matthew D. Galsky, MD

Session Two: Prostate Cancer, Moderator: Angelo De Marzo, MD, PhD

• The Rise, Fall and Resurrection of PROSTVAC , James Gulley, MD, PhD

Session Three: Kidney Cancer, Moderator: Brian Shuch, MD

• Dissecting the Tumor Immune Microenvironment of Clear Cell Renal Cell Carcinoma, Yousef Zakharia, MD
• Phenotyping the ccRCC TME to identify therapeutic strategies, A. Ari Hakimi, MD
• Targeting the Adenosine Pathway as Another Immune Checkpoint in Renal Cell Carcinoma , Lawrence Fong, MD

Session Four: General, Moderators: Peter Black, MD, FACS, FRCSC and William Kim, MD

• The Abscopal Effect Untangled, Kent W. Mouw, MD, PhD
• The Microbiome as an Immune Regulator, Karen S. Sfanos, PhD

Challenges in Urologic Research Symposium: Robotics, Artificial Intelligence and Machine Learning

Welcome and Opening Remarks, Craig Niederberger, MD, FACS

Session One: Robotics, Moderator: James M. Hotaling, MD, MS, FECSM

• Surgical Robots: A Platform for Enhancing Skill Assessment and Potential to Improve Performance, Ann Majewicz Fey, PhD
• Haptics and Augmented Reality, Cristian Luciano, PhD
• Microfluidic Sperm Sorting: A Case Study in the Power of Micromachines, James M. Hotaling, MD, MS, FECSM

Session Two: Artificial Intelligence (AI), Moderator: Daniel Moreira, MD

• Introduction to Artificial Intelligence, Richard M. Golden, PhD, MSEE, BSEE
• Artificial Intelligence in Medical Education, Daniel Moreira, MD
• Natural Language Processing for Clinical Research, Martin N. Kathrins, MD

Session Three: Machine Learning, Moderator: Craig Niederberger, MD, FACS

• Machine Learning in Pathology, Peter Gann, MD, ScD
• Artificial Intelligence and Computational Imaging for Precision Medicine of Prostate Cancer, Anant Madabhushi, PhD

Early-Career Investigators Showcase

Welcome and Introductions, Carolyn J.M. Best, PhD

Presentations Selected by Peer-Review Panel:

• An Investigation of the Physiology of Ureteral Contraction and the Adverse Effects of Stent Placement, Kymora B. Scotland, MD, PhD
• Abiraterone and enzalutamide are less effective when administered after long-term androgen deprivation therapy in a novel castration-resistant prostate cancer cellular model, Ignacio Puche-Sanz, MD, PhD
• Testosterone and Estrogen Supplementation Reverse Urethral Atrophy in Hypogonadal Rats, Matthias D. Hofer, MD, PhD
• Molecular Subtype in MIBC is Driven by Sex-Specific Differences, Sima P. Porten, MD, MPH, FACS
• CHD1-loss Promotes Tumor Heterogeneity and Antiandrogen Resistance, Ping Mu, PhD
• Phosphatidylserine as a Biomarker of Sperm Vitality and Fertilization Competency, Ryan P. Smith, MD
• Assessing the impact of telehealth insurance reform on telehealth utilization, Chad Ellimoottil, MD, MS
• Disparities in Use of Pre-Biopsy Prostate MRI for Medicare-Eligible Prostate Cancer Patients, Christopher P. Filson, MD, MS
• Employing Multiparametric Profiling to Characterize Immunotherapy Responders in Clear Cell Renal Cell Carcinoma, Brandon J. Manley, MD

10+ Scientific Posters from all Nominees: Topics Include Urologic Cancers, Urinary Stone Disease, Infertility, Health Services Research, and More!